VolparaEnterprise Data Analysis Shows Mammography Screening Volumes are Quickly Increasing
Risk and Automated Breast Density Assessment Helps Triage Patients to Supplemental Screening and Genetic Testing
Volpara Solutions Collaborating with DetectED-X to Make COVID-19 Diagnostic Training Modules Available to Radiologists
Volpara Sponsoring Free Virtual CME Course and Other Resources to Help during Pandemic Response
Derry Imaging Installs VolparaLive! the First Real-Time Quality Decision Support System for Mammography
VolparaLive! Automatically Analyzes Positioning and Compression Providing Feedback to Technologists Before the Patient Leaves the Mammography Room
Wellington, NZ, 15 January 2020: Volpara Health Technologies (“Volpara” or ”the Company”; ASX: VHT), a SaaS medical technology company whose AI imaging algorithms assist the early detection of breast cancer,...
Practice Management Tools Provide Access to Workflow and Image Quality Analytics to Help Improve Mammographic Quality and Maximize Resource Utilization.
Randomized Controlled Trial Reduces Interval Breast Cancers in Women Assessed as Extremely Dense by Volpara®Density™ Software
Clinical Decision-Support Tools Provide Radiologists Easy Access to Key Insights to Offer Women a Personalized Breast Care Plan
Wellington, NZ, October 29, 2019: Volpara Solutions, an industry leader in cancer screening workflow, today announced the expansion of its global Medical Advisory Board.
Volpara Signs Distribution Agreement to Sell Transpara™, Screenpoint Medical’s AI Solution for Breast Cancer Detection
Wellington, NZ, July 23, 2019 – Volpara Solutions and ScreenPoint Medical BV today announced signature of an agreement under which Volpara will sell ScreenPoint’s Transpara™ products to breast imaging clinics...